改善肝脏微循环障碍的必要性和相关中药的筛选

徐列明

改善肝脏微循环障碍的必要性和相关中药的筛选

徐列明

上海中医药大学附属曙光医院
上海中医药大学肝病研究所,肝肾疾病病证教育部重点实验室,上海市中医临床重点实验室

基金项目:

国家自然科学基金(No 30672489)；上海市教育委员会重点学科(第五期)建设项目(J50307)；上海市高校创新团队建设项目(第一期)；国家中医药管理局中医肝胆病重点学科(No:2010sh)；

详细信息

中图分类号: R259
计量
- 文章访问数: 3358
- HTML全文浏览量: 40
- PDF下载量: 747
- 被引次数: 0
出版历程
- 出版日期: 2013-04-20

Resolving blood stasis to improve liver microcirculation and treat chronic liver diseases

Xu LieMing

Research funding:

摘要

摘要:
慢性肝病常伴有肝脏微循环障碍,使得血液流动减慢甚至流量减少,导致门静脉高压。改善肝脏微循环与干预细胞外基质代谢在抗肝纤维化中具有同等的地位。现代医学的微循环障碍与中医学的瘀血含义有相同之处,应用有抗肝纤维化作用的活血化瘀中药或成分能够改善肝脏微循环、降低门静脉高压。介绍了体内外实验研究中药及组分改善肝脏微循环的作用及机制。
- 慢性肝病 /
- 微循环 /
- 高血压,门静脉 /
- 中草药 /
- 活血化瘀剂
Abstract:
Chronic liver diseases are frequently accompanied by changes in the organ′s microcirculatory system.Changes in the vascular architecture can affect the rate of blood flow, which in turn may promote the underlying pathogenic etiology;for example, recent studies have indicated that decreased blood flow in the liver can suppress the clearance rate of pathogenic agents (such as hepatitis virus) , enhance localized inflammation and or fibrosis-related injury, or increase pressure in the portal vein.The phenomenon of obstructed liver microcirculation in modern medicine is similar to the pathogenic concept of blood stasis in traditional Chinese medicine (TCM) .Thus, TCM decoctions or methods that promote blood circulation, and have been historically applied to remove blood stasis, may prove useful for treating liver diseases.In this review of the promising TCM agents and treatment modalities, we discuss not only the reported outcomes of pharmacological applications in both humans and animal models but also the molecular mechanisms related to the beneficial effects.Future studies should continue to investigate the clinical efficacy of resolving blood stasis to treat portal hypertension, liver fibrosis, and cirrhosis.
- chronic liver diseases /
- microcirculation /
- hypertension /
- portal /
- drugs

HTML全文

参考文献(23)

[1]Vollmar B, Menger.The hepatic microcirculation:mechanis-tic contributions and therapeutic targets in liver injury and re-pair[J].Physiol Rev, 2009, 89 (4) :1269-1339.

[2]Spengler U.Hepatic microcirculation:a critical but neglectedfactor for the outcome of viral hepatitis[J].J Hepatol, 2009, 50 (3) :631-633.

[3]McCuskey RS.The hepatic microvascular system in health andits response to toxicants[J].Anat Rec (Hoboken) , 2008, 291 (6) :661-671.

[4]Zhang J, Zhang WW, Xu LM.Effect and mechanism of salianic-acid B on inhibiting endothelin-1-induced contraction of hu-man hepatic stellate cells[J].Chin J Integr Tradit West Med, 2009, 29 (1) :60-64. (in Chinese) 张杰, 张文炜, 徐列明.丹参酚酸B盐对内皮素诱导的人肝星状细胞收缩的抑制作用及机制研究[J].中国中西医结合杂志, 2009, 29 (1) :60-64.

[5]Tian T, Xu LM.Effects of Salviae miltiorrhizae and salvianolicacid B on microcirculation of liver in mice with portal hyper-tension[J].Chin J Integr Tradit West Med, 2009, 7 (2) :151-156. (in Chinese) 田甜, 徐列明.丹参及其组分丹参酚酸B盐对门静脉高压小鼠肝脏微循环的影响[J].中西医结合学报, 2009, 7 (2) :151-156.

[6]Lu X, Xu GF, Chen WH, et al.Dynamic changes of hepaticsinusoidal capillarization during hepatic fibrosis in rats[J].World Chin J Dig, 2000, 8 (12) :1415-1416. (in Chinese) 陆雄, 徐光福, 陈文慧, 等.大鼠肝纤维化形成过程中肝窦毛细血管化的动态变化[J].世界华人消化杂志, 2000, 8 (12) :1415-1416.

[7]Shi M, Zhao HF.Blood stasis and hepatic microcirculation dis-turbance in liver disease patients treated by traditional Chinesemedicine[J].Hubei J Tradit Chin Med, 1993, 15 (5) :28-29. (in Chinese) 施敏, 赵会芳.中医肝病瘀血与肝脏微循环障碍[J].湖北中医杂志, 1993, 15 (5) :28-29.

[8] Chen KJ.Study on syndrome of blood stasis and activatingblood circulation to remove blood stasis[M].Shanghai:Shanghai Scientific&Technical Publishers, 1990:611. (inChinese) 陈可冀.血瘀证与活血化瘀研究[M].上海:上海科技出版社, 1990:611.

[9]Gu J, Zhou Y, Hong JH, et al.Effects of Fuzheng HuayuDecoction on elevated portal pressure in rat model of dimeth-ylnitrosamine-induced liver cirrhosis[J].World Chin J Dig, 2008, 16 (10) :1042-1046. (in Chinese) 顾杰, 周扬, 洪嘉禾, 等.扶正化瘀方对DMN肝硬化模型大鼠门静脉压力的影响[J].世界华人消化杂志, 2008, 16 (10) :1042-1046.

[10]Lu X, Liu P, Liu CH, et al.Effect of Fu Zheng Hua Yu Reci-pe on hepatic sinusoid capillarization in the rat of dimethyl ni-trosamine-induced hepatic fibrosis[J].J Tradit Chin Med, 2003, 44 (2) :136-139. (in Chinese) 陆雄, 刘平, 刘成海, 等.扶正化瘀方促进二甲基亚硝胺肝纤维化大鼠肝窦毛细血管化逆转作用的实验研究[J].中医杂志, 2003, 44 (2) :136-139.

[11]Zhou Y, Gu J, Xu LM.Effects of Salvianolic acid B on ele-vated portal pressure and hepatic endothelin-1 level in ratmodel of hepatocirrhosis[J].Chin J Integr Tradit West MedDigest, 2007, 15 (1) :4-7. (in Chinese) 周杨, 顾杰, 徐列明.丹参酚酸B盐对肝硬化大鼠门静脉高压及肝组织中内皮素-1的影响[J].中国中西医结合消化杂志, 2007, 15 (1) :4-7.

[12]Zhou Y, Gu J, Xu LM.Effect and mechanism of salvianolicacid B in attenuating elevated portal pressure in a rat modelof portal hypertension induced by endothelin-1[J].J ChinInterat Med, 2007, 5 (1) :61-64. (in Chinese) 周杨, 顾杰, 徐列明.丹参酚酸B盐抑制内皮素-1所致大鼠门静脉压力升高的药效及其作用机制[J].中西医结合学报, 2007, 5 (1) :61-64.

[13] Tian T, Xu LM.Effects of Salviae miltiorrhizae and salvianolicacid B on microcirculation of liver in mice with portal hyper-tension[J].Chin J Integr Tradit West Med, 2009, 7 (2) :151-156. (in Chinese) 田甜, 徐列明.丹参及其组分丹参酚酸B盐对门静脉高压小鼠肝脏微循环的影响[J].中西医结合学报, 2009, 7 (2) :151-156.

[14] Zhang J, Zhang WW, Xu LM.Effect and mechanism of salianic-acid B on inhibiting endothelin-1-induced contraction of hu-man hepatic stellate cells[J].Chin J Integr Tradit West Med, 2009, 29 (1) :60-64. (in Chinese) 张杰, 张文炜, 徐列明.丹参酚酸B盐对内皮素诱导的人肝星状细胞收缩的抑制作用及机制研究[J].中国中西医结合杂志, 2009, 29 (1) :60-64.

[15] Xu H.Study on inhibitory mechanism of salvianolic acid B a-gainst endothelin-induced contraction of hepatic stellatecells in rats[D].Shanghai:Shanghai University of T.C.M, 2009. (in Chinese) 徐虹.丹参酚酸B盐抑制内皮素诱导的大鼠肝星状细胞收缩的作用机制研究[D].上海:上海中医药大学, 2009.

[16] Zhou Y.Experimental study of inhibitory effect of salvianolicacid B on portal hypertension[D].Shanghai:Shanghai Uni-versity of T.C.M, 2005. (in Chinese) 周扬.丹参酚酸B盐降低门静脉高压的实验研究[D].上海:上海中医药大学, 2005.

[17]Xie SY, Niu FZ, Zhang R, et al.Forty-five cases of anginatreated by injection of breviscapine:the effect of breviscap-ine injection on plasma fibrinolytic activity[J].Liaoning J Tra-dit Chin Med, 1997, 24 (1) :21. (in Chinese) 谢淑英, 牛凤珍, 张锐, 等.灯盏花素注射液治疗心绞痛45例:附灯盏花素注射液对血浆纤溶活性的影响[J].辽宁中医杂志, 1997, 24 (1) :21.

[18]Lin Y, Luo ZR, Gai XB, et al.Changes in platelet functionand interference effects of breviscapine in patients with coro-nary heart disease[J].Fujian J Tradit Chin Med, 2005, 33 (2) :5. (in Chinese) 林毅, 罗助荣, 盖晓波, 等.冠心病患者血小板功能的变化及灯盏花素的干预作用[J].福建中医药, 2005, 33 (2) :5.

[19]Wang XS, Ruan XZ, Liu ML.Study of erigeron on brain protec-tion after cerebral ischemia and reperfusion in rats[J].ChinTradit Patent Med, 2002, 24 (12) :947-950. (in Chinese) 王雪松, 阮旭中, 刘买利.灯盏花素对缺血再灌注鼠脑损伤的脑保护作用研究[J].中成药, 2002, 24 (12) :947-950.

[20]Jia JH, Chen SX, Su YX, et al.Protective effects of Breviscap-ine on myocardial ischemic reperfusion injury of rats[J].J Jian-gsu Univ (Med Edit) , 2006, 16 (6) :477-480. (in Chinese) 贾俊海, 陈素仙, 苏一星, 等.灯盏花素对大鼠心肌缺血再灌注损伤的保护作用[J].江苏大学学报:医学版, 2006, 16 (6) :477-480.

[21]Cui HL, Hu WJ, Feng F, et al.Clinical efficacy of breviscap-ine combined with phentolamine in treatment of ascites dueto cirrhosis[J].Chin Hepatol, 2010, 15 (6) :441-442. (inChinese) 崔洪岭, 胡文杰, 封飞, 等.灯盏花素联合酚妥拉明治疗肝硬化腹水临床观察[J].肝脏, 2010, 15 (6) :441-442.

[22]Chen YP.Effects of Deng Zhan Hua Su on microcirculationand fibrosis indices in hepatic cirrhosis[J].Heilongjiang MedPharm, 2006, 23 (5) :10. (in Chinese) 陈咏萍.灯盏花素对肝硬化微循环和纤维化指标的影响[J].黑龙江医药科学, 2006, 23 (5) :10.

[23]Du GJ, Wang M, Lin HH, et al.Protective effects of brevis-capine against hepatic fibrosis[J].J Henan Univ (Med Sci) , 2009, 28 (3) :170-176. (in Chinese) 杜钢军, 王梅, 林海红, 等.灯盏花素的肝纤维化保护作用[J].河南大学学报 (医学版) , 2009, 28 (3) :170-176.

施引文献

资源附件(0)

访问统计